Lineage Cell Therapeutics Inc (NYSE American:LCTX)
| 1.40 Delayed Data As of 3:59pm ET |  -0.06 / -4.11%Today’s Change | 1.02 Today|||52-Week Range 1.79 | +19.66% Year-to-Date |
Latest LCTX News | Press Releases
No recent news for Lineage Cell Therapeutics Inc.
Today’s Trading
| Previous close | 1.46 |
| Today’s open | 1.44 |
| Day’s range | 1.39 - 1.44 |
| Volume | 217,114 |
| Average volume (3 months) | 377,918 |
| Market cap | $246.7M |
Data as of 3:59pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +40.84% |
| Earnings growth (this year) | -10.48% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +277.39% |
| P/E ratio | NM |
| Price/Sales | 13.51 |
| Price/Book | 3.36 |
Competitors
Data as of 3:59pm ET, 03/27/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $14.7M |
| Annual profit (last year) | -$26.3M |
| Net profit margin | -178.69% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Carlsbad, California |
Forecasts
